Neutralizing activity to SARS-CoV-2 of convalescent and control plasma used in a randomized controlled trial.

Alex T FreedenbergChun-Hao PanWilliam E DiehlJamie L RomeiserGa-Ram HwangCindy V LeitonFrauke MückschKenneth R ShroyerElliott Bennett-Guerrero

Published in: Transfusion (2021)

Plasma from donors screened using an immunochromatographic test for IgG antibody to SARS-CoV-2 NP exhibited neutralizing activity meeting FDA's minimum standard in all randomly selected COVID-19 CP units.

Keyphrases

sars cov
respiratory syndrome coronavirus
dengue virus
coronavirus disease